HealthCare News Headline
Long-Acting HIV Drug May Offer Better Protection Against Infection
TUESDAY, March 4, 2014 (HealthDay News) -- A long-acting, injectable HIV drug could potentially protect people from infection with the AIDS virus for up to three months, new animal studies suggest.
The experimental drug, called GSK744, protected macaque monkeys from repeated attempts to infect the animals with a hybrid simian/human AIDS virus called SHIV, scientists said.Read entire article...
Some others: Androgel, Duraclon, Marevan, Chantix, Indapamide, Nidagel, Megestrole, Parotur, Carbex, ACV, ...
Heart Risks Rise With Smokeless Tobacco
THURSDAY, Aug. 20 (HealthDay News) -- Smokeless tobacco increases the risk of fatal heart attack and stroke, say researchers who reviewed the results of 11 studies conducted in North America and Sweden.
In recent decades, the researchers noted, the use of smokeless tobacco products has increased in Europe and North America, particularly among people younger than 40, partly because the products are promoted as safer alternatives to cigarettes.
However, their review found that users of smokeless tobacco products had a slightly higher risk of death from heart attack and stroke than non-users. Smokeless tobacco was linked with 0.5 percent of all heart attacks in the United States and 5.6 percent in Sweden, and 1.7 percent of all deaths from stroke in the United States and 5.4 percent in Sweden, according to the report in the Aug. 18 online edition of BMJ.
The increased risk is small, but the consistency of the results among the studies included in the review suggests that the findings are credible, according to the researchers, led by Dr. Paolo Boffetta, of the International Agency for Research on Cancer in France. Read entire article...
Copyright © 2016 Prescription-Mexico.com
Terms of Service